SANGAMO THERAPEUTICS, INC. Deferred Tax Assets, Deferred Income
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Deferred Tax Assets, Deferred Income of $1.48 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Deferred Income $1.48M.
- 2024-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2023-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2022-12-31: Deferred Tax Assets, Deferred Income $38.70M.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2025-12-31 | $1.48M 10-K · filed 2026-03-30 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-17 |
| 2022-12-31 | $38.70M 10-K · filed 2024-03-13 |
| 2021-12-31 | $61.11M 10-K · filed 2023-02-23 |
| 2020-12-31 | $20.68M 10-K · filed 2022-02-24 |
| 2019-12-31 | $32.17M 10-K · filed 2021-02-24 |
| 2018-12-31 | $3.19M 10-K · filed 2020-02-28 |
| 2017-12-31 | $934.00K 10-K · filed 2019-03-01 |
| 2016-12-31 | $2.92M 10-K · filed 2018-03-01 |
| 2015-12-31 | $4.48M 10-K · filed 2017-02-28 |
| 2014-12-31 | $2.69M 10-K · filed 2016-02-18 |
| 2013-12-31 | $3.56M 10-K · filed 2015-02-25 |